NR 566 Advanced Pharmacology for Care of the Family –
FINAL EXAM 2025 VERSION WITH 160 VERIFIED
QUESTIONS || 100% GUARANTEED PASS
Description:
This document includes the 2025 Final Exam for NR 566: Advanced Pharmacology for Care of
the Family, featuring 160 verified and up-to-date questions. Topics covered include
pharmacokinetics, drug interactions, prescribing across the lifespan, and safe medication
management. All answers are correct and thoroughly reviewed, making this resource ideal for
nurse practitioner students preparing for their final assessment.
Keywords:
NR 566 final exam
advanced pharmacology exam
family nurse practitioner pharmacology
drug therapy across the lifespan
pharmacokinetics and pharmacodynamics
prescribing safety NP
2025 NR 566 questions
nurse practitioner exam prep
1.
Q: What is the mechanism of action of ACE inhibitors in hypertension management?
A: ACE inhibitors block the conversion of angiotensin I to angiotensin II, causing vasodilation and
decreased aldosterone secretion. This reduces blood pressure by lowering systemic vascular
resistance and promoting sodium and water excretion, ultimately decreasing preload and
afterload on the heart.
, 2
2.
Q: What are common side effects of beta-blockers?
A: Beta-blockers can cause bradycardia, fatigue, hypotension, bronchospasm, and sexual
dysfunction. They reduce heart rate and contractility, which helps in hypertension and
arrhythmias but may exacerbate asthma or COPD due to bronchoconstriction.
3.
Q: How does metformin work to control blood glucose in type 2 diabetes?
A: Metformin decreases hepatic glucose production, increases insulin sensitivity in peripheral
tissues, and improves glucose uptake by muscles, resulting in lowered blood sugar without
stimulating insulin secretion, minimizing risk of hypoglycemia.
4.
Q: What is the primary adverse effect to monitor when prescribing statins?
A: The main concern is myopathy and rhabdomyolysis. Monitor for muscle pain or weakness
and check creatine kinase levels. Statins can also cause liver enzyme elevations, so liver function
tests are important.
5.
Q: Describe the therapeutic use of SSRIs in mental health.
A: SSRIs increase serotonin availability in synaptic clefts by inhibiting reuptake. They are used to
treat depression, anxiety disorders, OCD, and PTSD by improving mood and anxiety regulation
with fewer side effects compared to older antidepressants.
, 3
6.
Q: What are the contraindications of using NSAIDs in patients?
A: NSAIDs are contraindicated in patients with active peptic ulcer disease, severe renal
impairment, bleeding disorders, or allergy to NSAIDs due to risk of gastrointestinal bleeding,
nephrotoxicity, and hypersensitivity reactions.
7.
Q: Explain how warfarin acts as an anticoagulant.
A: Warfarin inhibits vitamin K epoxide reductase, reducing activation of vitamin K-dependent
clotting factors II, VII, IX, and X, which impairs the coagulation cascade and prevents thrombus
formation. Requires close INR monitoring to balance bleeding risk.
8.
Q: What is the role of glucocorticoids in asthma treatment?
A: Glucocorticoids reduce airway inflammation by suppressing cytokine production and
inflammatory cell infiltration. They decrease airway hyperresponsiveness, mucus production,
and swelling, improving airflow and preventing asthma exacerbations.
9.
Q: How do calcium channel blockers reduce hypertension?
A: They block calcium influx into vascular smooth muscle and cardiac myocytes, causing
vasodilation and decreased myocardial contractility. This lowers peripheral vascular resistance
and cardiac workload, effectively reducing blood pressure.
, 4
10.
Q: What are signs of lithium toxicity?
A: Early signs include nausea, vomiting, diarrhea, and tremors. Severe toxicity manifests as
confusion, ataxia, seizures, and renal failure. Lithium has a narrow therapeutic window, so
regular blood level monitoring is essential.
11.
Q: What drug interactions are critical to monitor with theophylline?
A: Theophylline metabolism is affected by CYP450 inducers/inhibitors such as phenytoin,
cimetidine, and erythromycin. Toxicity risk increases with inhibitors, causing nausea,
arrhythmias, and seizures, requiring dose adjustments.
12.
Q: Describe the use of proton pump inhibitors (PPIs).
A: PPIs irreversibly inhibit gastric H+/K+ ATPase, reducing acid secretion. Used in GERD, peptic
ulcers, and Zollinger-Ellison syndrome. Long-term use risks include osteoporosis, C. difficile
infection, and vitamin B12 deficiency.
13.
Q: What is the main therapeutic effect of digoxin?
A: Digoxin increases cardiac contractility (positive inotropy) by inhibiting the Na+/K+ ATPase
pump, improving cardiac output in heart failure. It also slows AV node conduction, helping
control atrial fibrillation.